Mulham David Mulham's Form 4 filing
Usana Health Sciences Inc (USNA) · filed Nov 12, 2021
- Accession no.
- 0001179110-21-010088
- Filed
- Nov 12, 2021
- Trade date
- Nov 11, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $111.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mulham David MulhamCIK 0001697433 | Officer (Chief Field Development Office) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2021 | Common Stock | SSaleDisposed | −1,111 | $100.74F1 | −$111,922.14 | 5,523 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Weighted average price $100.74. Price range in multiple transactions was $100.47 to $101.00 inclusively.
Referenced by the price of 1 transaction in Table I.